Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU ...

Washington University researchers found that raising a molecule called ApoM helps eye cells sweep away harmful cholesterol ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

Toll-like receptors, or TLRs, are the immune system’s early warning sensors. They detect microbial invaders and damage ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults.

Ohio State University. (2024, July 2). A new target for treatment of one type of macular degeneration. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 07 ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types According to DelveInsight’s analysis, the market for age-related macular degeneration is ...

Can AI really replace scientists? Robin, an AI system, identified a potential drug for vision loss, but scientists are skeptical of full research automation.

A new genetic study found a surprising link between instant coffee and age-related macular degeneration, which can’t be cured ...